title: Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two Cases.
abstract: Health-related direct-to-consumer (DTC) genetic testing has been a controversial practice. Especially problematic is predictive testing for Alzheimer disease (AD), since the disease is incurable, prevention is inconclusive, and testing does not definitively predict an individual's future disease status. In this paper, I examine two contrasting cases of subjects who learn through genetic testing that they have an elevated risk of developing AD later in life. In these cases, the subject's emotional response to the result is related to how well prepared she was for the real-life personal implications of possible test results. Analysis leads to the conclusion that when groups of health-related genetic tests are offered as packages by DTC companies, informed consumer choice is rendered impossible. Moreover, I argue, this marketing approach contravenes U.S. Federal Trade Commission policies for non-deceptive commercial communications. I conclude by suggesting ways to improve the prospects for informed consumer choice in DTC testing.
authors: Penn Center for the Integration of Genetic Technologies, Department of Medical Genetics, University of Pennsylvania, Philadelphia, PA, USA.
authors: Donna A
authors: DA
authors: Messner
references: New Genet Soc. 2006 Apr;25(1):89-107
references: 17312631
references: Hastings Cent Rep. 2001 May-Jun;31(3):33-5
references: 11478123
references: J Clin Oncol. 2003 Sep 1;21(17):3191-3
references: 12874271
references: JAMA. 1995 Nov 22-29;274(20):1627-9
references: 7474250
references: Lancet. 1996 Apr 20;347(9008):1091-5
references: 8602063
references: Kennedy Inst Ethics J. 1998 Jun;8(2):131-44
references: 11657425
references: Alzheimer Dis Assoc Disord. 1995 Winter;9(4):182-7
references: 8749605
references: Med Clin North Am. 2002 May;86(3):591-614
references: 12171060
references: Trends Genet. 2010 May;26(5):199-201
references: 20381895
references: IRB. 1979 Oct;1(6):1-4
references: 11661753
references: Science. 1997 Oct 24;278(5338):602-5
references: 9381169
references: Arch Gen Psychiatry. 2006 Feb;63(2):168-74
references: 16461860
references: BMJ. 2001 Apr 28;322(7293):1052-6
references: 11325775
references: JAMA. 1997 Oct 22-29;278(16):1349-56
references: 9343467
references: Hastings Cent Rep. 1998 Jul-Aug;28(4):15-21
references: 9762534
references: JAMA. 2002 Oct 9;288(14):1762-7
references: 12365961
references: Spec Law Dig Health Care Law. 2006 Jun;(326):9-41
references: 17249292
references: Neurology. 2004 May 11;62(9):1631-3
references: 15136700
references: Health Educ Behav. 2005 Oct;32(5):676-85
references: 16148213
references: Oklahoma Law Rev. 2004 Summer;57(2):251-302
references: 15658034
references: Genet Med. 2008 Apr;10(4):231-9
references: 18414205
references: Genet Med. 2004 Jul-Aug;6(4):197-203
references: 15266207